Back to search

Article

The Low Expression Of ALDOB Is Associated With Poor Prognosis In Renal Clear Cell Carcinoma

2022-11-30

Abstract excerpt

<h4>Objective: </h4> Fructose bisphosphate aldolase (ALDOB) is a glycolytic metabolic enzyme, which is considered to be a therapeutic target for many cancers. However, ALDOB expression level and its regulatory mechanism in renal clear cell carcinoma is not clear. To explore ALDOB expression level and its regulatory mechanism in renal clear cell carcinoma we downloaded gene expression data sets and analyzed them by...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
309f2533-d2b4-5968-89d9-54f75e392657
DOI
10.21203/rs.3.rs-2254556/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Low Expression Of ALDOB Is Associated With Poor Prognosis In Renal Clear Cell CarcinomaDOI 10.21203/rs.3.rs-2254556/v1
Select a neighboring publication to make it the new centre.